Nrc Health (NRC) Gains from Investment Securities (2010 - 2025)

Nrc Health has disclosed Gains from Investment Securities across 16 years of filings, most recently posting $141000.0 for Q4 2025.

• Gains from Investment Securities for Q4 2025 came in at $141000.0, up 6950.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $241000.0 (up 2086.73% YoY), and the FY2025 annual result was $608782.0, up 1016.42% from the prior year.
• Gains from Investment Securities came in at $141000.0 for Q4 2025 at Nrc Health, up from $49000.0 in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $10.3 million in Q4 2021 to a low of -$165000.0 in Q4 2022.
• The 5-year median for Gains from Investment Securities is $96359.0 (2023), against an average of $1.1 million.
• Across the five-year window, Gains from Investment Securities soared 22236.96% in 2021 and plunged 101.61% in 2022, its largest moves.
• Nrc Health's Gains from Investment Securities stood at $10.3 million in 2021, then slumped by 101.61% to -$165000.0 in 2022, then jumped by 5513.33% to $8.9 million in 2023, then tumbled by 99.98% to $2000.0 in 2024, then surged by 6950.0% to $141000.0 in 2025.
• The last three Gains from Investment Securities figures came in at $141000.0 (Q4 2025), $49000.0 (Q3 2025), and $51000.0 (Q2 2025), per Business Quant data.